These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 22526099

  • 21. Yttrium-90 Hepatic Radioembolization for Advanced Chemorefractory Metastatic Colorectal Cancer: Survival Outcomes Based on Right- Versus Left-Sided Primary Tumor Location.
    Wu V, Li MD, Goodwin JS, Wehrenberg-Klee EP, Zurkiya O, Kalva SP, Ganguli S.
    AJR Am J Roentgenol; 2021 Nov; 217(5):1141-1152. PubMed ID: 33594907
    [Abstract] [Full Text] [Related]

  • 22. Survival outcomes of a salvage patient population after radioembolization of hepatic metastases with yttrium-90 microspheres.
    Evans KA, Richardson MG, Pavlakis N, Morris DL, Liauw W, Bester L.
    J Vasc Interv Radiol; 2010 Oct; 21(10):1521-6. PubMed ID: 20813542
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival.
    Hilgard P, Hamami M, Fouly AE, Scherag A, Müller S, Ertle J, Heusner T, Cicinnati VR, Paul A, Bockisch A, Gerken G, Antoch G.
    Hepatology; 2010 Nov; 52(5):1741-9. PubMed ID: 21038413
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following yttrium-90 radioembolization.
    Camacho JC, Kokabi N, Xing M, Prajapati HJ, El-Rayes B, Kim HS.
    J Vasc Interv Radiol; 2014 Feb; 25(2):256-65. PubMed ID: 24461131
    [Abstract] [Full Text] [Related]

  • 27. Combined Effects of Yttrium-90 Transarterial Radioembolization around Immunotherapy for Hepatic Metastases from Uveal Melanoma: A Preliminary Retrospective Case Series.
    Zheng J, Irani Z, Lawrence D, Flaherty K, Arellano RS.
    J Vasc Interv Radiol; 2018 Oct; 29(10):1369-1375. PubMed ID: 30174161
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Is yttrium-90 radioembolization a viable treatment option for unresectable, chemorefractory colorectal cancer liver metastases? A large single-center experience of 302 patients.
    Saxena A, Meteling B, Kapoor J, Golani S, Morris DL, Bester L.
    Ann Surg Oncol; 2015 Mar; 22(3):794-802. PubMed ID: 25323474
    [Abstract] [Full Text] [Related]

  • 31. Patterns of failure in colorectal patients with liver metastases after yttrium-90 radioembolization.
    Schonewolf CA, Patel B, Gensure RH, Narra V, Haffty BG, Nosher JL, Jabbour SK.
    Am J Clin Oncol; 2014 Jun; 37(3):234-40. PubMed ID: 23275270
    [Abstract] [Full Text] [Related]

  • 32. Validation of several SUV-based parameters derived from 18F-FDG PET for prediction of survival after SIRT of hepatic metastases from colorectal cancer.
    Fendler WP, Philippe Tiega DB, Ilhan H, Paprottka PM, Heinemann V, Jakobs TF, Bartenstein P, Hacker M, Haug AR.
    J Nucl Med; 2013 Aug; 54(8):1202-8. PubMed ID: 23729697
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres.
    Mulcahy MF, Lewandowski RJ, Ibrahim SM, Sato KT, Ryu RK, Atassi B, Newman S, Talamonti M, Omary RA, Benson A, Salem R.
    Cancer; 2009 May 01; 115(9):1849-58. PubMed ID: 19267416
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Yttrium-90 Radioembolization as Salvage Therapy for Liver Metastases From Colorectal Cancer.
    Kalva SP, Rana RS, Liu R, Rachamreddy N, Dave B, Sharma A, Ganguli S, Rabito C, Kwak E, Blaszkowsky LS.
    Am J Clin Oncol; 2017 Jun 01; 40(3):288-293. PubMed ID: 25374143
    [Abstract] [Full Text] [Related]

  • 38. 90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival.
    Bangash AK, Atassi B, Kaklamani V, Rhee TK, Yu M, Lewandowski RJ, Sato KT, Ryu RK, Gates VL, Newman S, Mandal R, Gradishar W, Omary RA, Salem R.
    J Vasc Interv Radiol; 2007 May 01; 18(5):621-8. PubMed ID: 17494843
    [Abstract] [Full Text] [Related]

  • 39. Yttrium-90 radioembolization as a bridge to liver transplantation: a single-institution experience.
    Tohme S, Sukato D, Chen HW, Amesur N, Zajko AB, Humar A, Geller DA, Marsh JW, Tsung A.
    J Vasc Interv Radiol; 2013 Nov 01; 24(11):1632-8. PubMed ID: 24160821
    [Abstract] [Full Text] [Related]

  • 40. Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas after hepatic arterial embolization.
    Murthy R, Kamat P, Nunez R, Madoff DC, Gupta S, Salem R, Yao JC.
    J Vasc Interv Radiol; 2008 Jan 01; 19(1):145-51. PubMed ID: 18192482
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.